Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT05293964 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05293964
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2024-12-31
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.